Submit your abstract

Late breaking abstracts submission is now closed.

Watch the tutorial on 'How to get your abstract accepted and how to present' it by Geoff Daniels

Abstract submission is closed

An international panel of experts will review and select abstracts for oral or poster presentation. The first (presenting) author will receive a confirmation of acceptance for either an oral or poster presentation, or a notice of rejection, by email by the end of October.

ABSTRACT TOPICS

1.1 Organisational issues

1.2 Information technology

1.3 Cost/effectiveness

1.4 Training and education

1.5 Risk models, standards and regulation

1.6 Blood supply management and utilization - but not blood group or clinically related

1.7 Quality management

2.1 Blood donor recruitment and retention

2.2 Blood donor health

2.3 Blood collection including apheresis

2.4 Donor adverse events

3.1 Blood processing, storage and release
3.2 Blood components
3.3 Plasma products
3.4 Pathogen inactivation
3.5 Novel blood products

4.1 Screening strategies for TTI
4.2 Hepatitis B (HBV)
4.3 Hepatitis C (HCV)
4.4 HIV
4.5 Bacteria
4.6 Parasites
4.7 Newly emerging pathogens and other transfusion related pathogens

5.1 Red cell immunology: Serology
5.2 Red cell immunology: Molecular
5.3 Platelet immunology
5.4 Granulocyte immunology
5.5 Fetal-maternal immunology

6.1 Neonatal and pediatric transfusion

6.2 Therapeutic apheresis

6.3 Evidence based transfusion medicine practice

6.4 Haemorrhage and massive transfusion

6.5 Adverse events, including TRALI

6.6 Haemovigilance and transfusion safety

6.7 Alternatives to blood transfusion

6.8 Patient Blood Management

6.9 Transfusion practitioner related clinical practice improvement - Abstracts MUST address how the transfusion practitioner (TP ) has been involved with/or led clinical transfusion practice improvements that could relate to: Safety and appropriate use of blood and blood products, patient blood management initiatives, haemovigilance, education, activities to improve patient safety and audit.

 

 

 

7.1 Stem cell and tissue banking, including cord blood
7.2 Collection, processing, storage and release
7.3 Clinical applications

8.1 HLA in transfusion medicine
8.2 Histocompatibility in stem cell transplantation
8.3 Histocompatibility in organ transplantation

JOIN ISBT TOGETHER WE INCREASE OUR IMPACT ON TRANSFUSION MEDICINE

Quote
Quote

“I think ISBT is the main forum for translating science and networking into best practices”

Morten Bagge Hansen, Denmark
Become a member of ISBT Join us now